| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/08/2004 | EP1453805A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 09/08/2004 | EP1453798A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2004 | EP1453796A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
| 09/08/2004 | EP1453795A2 Esters and amides as ppar-alpha agonists |
| 09/08/2004 | EP1453793A2 New pharmaceutical compounds |
| 09/08/2004 | EP1453792A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453788A1 Substituted hydroxyethylamines |
| 09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
| 09/08/2004 | EP1453777A1 Functionalized higher diamondoids |
| 09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
| 09/08/2004 | EP1453528A2 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 09/08/2004 | EP1453525A1 Selective targeting of apoptotic cells |
| 09/08/2004 | EP1453522A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist |
| 09/08/2004 | EP1453521A1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 09/08/2004 | EP1453512A1 Acetylene derivatives having mglur 5 antagonistic activity |
| 09/08/2004 | EP1453511A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 09/08/2004 | EP1453510A2 Neurotransmitter balance chemotherapy |
| 09/08/2004 | EP1453508A1 Tempamine compositions and use against cellular oxidative damage |
| 09/08/2004 | EP1453505A2 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 09/08/2004 | EP1453499A1 Use of 2-hydroxy or 2-acetyloxy-4-trifluoro-methylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment |
| 09/08/2004 | EP1453495A2 Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists |
| 09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/08/2004 | EP1397503A4 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore |
| 09/08/2004 | EP1379261A4 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1324761A4 Uridine therapy for patients with elevated purine levels |
| 09/08/2004 | EP1267853B1 Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease |
| 09/08/2004 | EP1122243B1 Novel imidazoles with anti-inflammatory activity |
| 09/08/2004 | EP1094712A4 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 09/08/2004 | EP1089994B1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 09/08/2004 | EP1064021B1 Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis. |
| 09/08/2004 | EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 09/08/2004 | EP0994876B1 Quaternary ammonium compounds as tachykinin antagonists |
| 09/08/2004 | EP0835127B1 Composition containing a myelin-associated glycoprotein (mag) inhibitor which comprises an altered or mutated form of mag |
| 09/08/2004 | EP0729455B1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/08/2004 | CN1527840A Use of CD 25 binding molecules in steroid-resistant patients |
| 09/08/2004 | CN1527839A Modified human brain-derived neutrophic factor (BDNF) with reduced immunogenicity |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
| 09/08/2004 | CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
| 09/08/2004 | CN1527825A Method for the preparation of escitalopram |
| 09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 09/08/2004 | CN1527823A Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 09/08/2004 | CN1527822A Thiazole derivatives for treating PPAR related disorders |
| 09/08/2004 | CN1527820A 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 09/08/2004 | CN1527818A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527816A New indole derivatives with 5-HT6 receptor affinity |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527813A ANtioxidant nitroxides and nitrones as therapeutic agents |
| 09/08/2004 | CN1527723A Methods for treating or preventing skin disorders using CD2-binding agents |
| 09/08/2004 | CN1527718A Method for short-term and long-term drug dosimetry |
| 09/08/2004 | CN1527717A Remedies |
| 09/08/2004 | CN1527713A Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 09/08/2004 | CN1527712A Active ingredient combination for medicamentous therapy of nicotine dependency |
| 09/08/2004 | CN1527711A Active substance combination for medicamentous therapy of habituation of or habitual material or narcotics |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1527708A Medicinal composition for treating interstitial cystitis |
| 09/08/2004 | CN1527705A Pharma ceutical formulation containing and LTB4 antagonist |
| 09/08/2004 | CN1527700A Compaction process for manufacture of sodium phenytoin dosage form |
| 09/08/2004 | CN1526443A Deep sleep promoter and its prepn and application |
| 09/08/2004 | CN1526441A Agastache capsule for restoring healthy energy andits prepn and application |
| 09/08/2004 | CN1526435A Medicine for treating amnesia and dementia |
| 09/08/2004 | CN1526425A Acupoint injecting medicine liquid for treating femoral head necrosis |
| 09/08/2004 | CN1526409A Medicated food for preventing and treating several kinds of diseases such as: alcoholism, fatty liver, diabetes and its making process |
| 09/08/2004 | CN1526400A Tubiflorous desert cistanche prepn containing phenethyl alcohol glycoside and its prepn process and use |
| 09/08/2004 | CN1526394A Buspirone hydrochloride guttate pills and the prepn |
| 09/08/2004 | CN1526385A Ditropan hydrochloride dripping pills and the prepn process |
| 09/08/2004 | CN1526382A Sertraline hydrochloride dripping pills and the prepn |
| 09/08/2004 | CN1165539C Oxazinocarbazoles for the treatment of CNS diseases |
| 09/08/2004 | CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents |
| 09/08/2004 | CN1165343C Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 09/08/2004 | CN1165337C Synthetic cryptophycins |
| 09/08/2004 | CN1165333C Compound body-strenghthening eucommia bark mixture for treating diseases caused by kidney Qi deficiency |
| 09/08/2004 | CN1165332C Medicine composition for treatnig epilepsy |
| 09/08/2004 | CN1165330C Chinese herb medicine preparation for improving sleeping |
| 09/08/2004 | CN1165311C Slow-releasing coposition of estrogen medicine and its preparing process |
| 09/08/2004 | CN1165307C Controlled release oxycodone compositions |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787641 Identification of sel-12 and uses thereof |
| 09/07/2004 | US6787566 Breakers of advanced glycation endproducts |
| 09/07/2004 | US6787562 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 09/07/2004 | US6787560 Serotonin reuptake inhibitor |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787552 PPAR delta activators |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787541 Thieno-and furopyrimidine derivatives as A2A-receptor antagonists |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787539 2,4,5,-trisubstituted pyrimidine derivatives |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/07/2004 | US6787535 Indole derivatives with 5HT6 receptor affinity |
| 09/07/2004 | US6787521 Skin disorders; kidney and liver disorders |
| 09/07/2004 | US6787519 Methods of treating disorders related to apoE |
| 09/07/2004 | US6787517 Agent and methods for treating pain |